Faculty members at the Jacobs School of Medicine and Biomedical Sciences are working collaboratively with doctors throughout the U.S. to learn more about a new link they are seeing in some patients between COVID-19 and stroke. And it is occurring in an unexpected population.
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).
Two Jacobs School of Medicine and Biomedical Sciences’ researchers studying how to develop novel, non-addicting painkillers have each been issued awards by the Helping to End Addiction Long-term (HEAL) Initiative, a prestigious and highly competitive program from the National Institutes of Health.
Researchers have developed a way to generate 3D prints of the human vascular system, giving surgeons pre-surgical, hands-on access to individual patients’ life-threatening vascular diseases in the heart and brain.
Twenty faculty members with a variety of clinical and research experience — representing nine medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences during the past several months.